BROADWOOD CAPITAL INC Long-Term Concentrated

CIK: 0001278387 · Show all filings

Period: Q3 2021 (← Previous) (Next →)

Filing Date: Nov 15, 2021

Total Value ($000): $1,961,407 (100.0% shares, 0.0% debt)

Holdings (7)

STAA STAAR SURGICAL CO 56.8%

Value ($000) $1,113,530 Shares 8,663,584 Est. Cost $8.21 Unrealized +1604.4%

MNST MONSTER BEVERAGE CORP NEW 21.1%

Value ($000) $413,636 Shares 4,656,488 Est. Cost $22.71 Unrealized +108.2%

IWM ISHARES TR 7.7%

Value ($000) $150,938 Shares 690,000 Est. Cost $112.69 Unrealized —

AXON AXON ENTERPRISE INC 6.8%

Value ($000) $133,026 Shares 760,062 Est. Cost $27.50 Unrealized +560.7%

LCTX LINEAGE CELL THERAPEUTICS IN 4.4%

Value ($000) $85,694 Shares 34,005,379 Est. Cost $1.03 Unrealized +148.9%

— ONCOCYTE CORP 3.1%

Value ($000) $61,766 Shares 17,349,945 Est. Cost $3.38 Unrealized —

— AGEX THERAPEUTICS INC 0.1%

Value ($000) $2,817 Shares 2,997,156 Est. Cost $2.99 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
STAA	STAAR SURGICAL CO	8,663,584	$1,113,530	56.8%	$8.21	+1604.4%	COM PAR $0.01	852312305
MNST	MONSTER BEVERAGE CORP NEW	4,656,488	$413,636	21.1%	$22.71	+108.2%	COM	61174X109
IWM	ISHARES TR	690,000	$150,938	7.7%	$112.69	—	RUSSELL 2000 ETF	464287655
AXON	AXON ENTERPRISE INC	760,062	$133,026	6.8%	$27.50	+560.7%	COM	05464C101
LCTX	LINEAGE CELL THERAPEUTICS IN	34,005,379	$85,694	4.4%	$1.03	+148.9%	COM	53566P109
—	ONCOCYTE CORP	17,349,945	$61,766	3.1%	$3.38	—	COM	68235C107
—	AGEX THERAPEUTICS INC	2,997,156	$2,817	0.1%	$2.99	—	COM	00848H108